Zenas BioPharma, Inc Common Stock
Price & Volume
Stats
See more52W Range | $6.11-$44.60 |
Market Cap | $1.9B |
Shares Short | 8M |
Financials
See moreRevenue (12 Mos) | $15M |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$146.5M |
Diluted EPS | $13.67 |
News
See moreYahoo Finance • 2 days ago
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 8 days ago
CD19 Inhibitors Market to Witness Significant Expansion During the Forecast Period (2025-2034) as Autoimmune and Oncology Pipelines Accelerate | DelveInsight
Yahoo Finance • 18 days ago
Zenas BioPharma, Inc. (ZBIO): A Bull Case Theory
Yahoo Finance • 27 days ago
Encouraging Phase II Trial Data Supported Zenas BioPharma (ZBIO) in Q4
About
CEO | Mr. Leon Oliver Moulder Jr., M.B.A. |
CFO | Ms. Jennifer A. Fox |
Address | 852 Winter Street, Waltham, MA, United States, 02451 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 130 |
